top of page
"Question the protocol": Western Blotting close to the Patient
An interview with Glenda Alquicer, PhD, research scientist at the Department of Experimental Rheumatology, Institute of Rheumatology, Prague After twenty years at the bench, Glenda Alquicer is working, for the first time, directly with the disease she studies. At the Institute of Rheumatology in Prague, she grows cells from patients’ synovial tissue and tests nanoparticle-delivered drugs and cannabinoid receptor agonists on them — with each patient’s full treatment history at
Nov 57 min read
VerdiBlot is coming to Lab Innovations 2026 in Birmingham
We are excited to announce that VerdiBlot will exhibit at Lab Innovations 2026, taking place on 4–5 November at the NEC Birmingham. You will find us in Hall 2, stand D81. A meeting point for the UK laboratory community For VerdiBlot, Lab Innovations is a valuable opportunity to meet the UK laboratory community, learn directly from researchers and build new relationships with laboratories, companies and potential distribution partners. Lab Innovations brings scientists, resear
Oct 223 min read
Juan Manuel Gonzalez Morena: Controls are more important than a beautiful blot
Juan studies how tumor suppressors kill cancer cells, works as a postdoc at IOCB Prague and as Head of Biology at Taveren Therapeutics, and runs a Western blot almost every day. We talked about the work, about experiments that don’t work and tips which could be useful to all scientist. What do you do, and what does a normal day in the lab look like for you? J: I am a cancer biologist. Most of my work is about understanding the molecular mechanisms that tumor suppressors use t
Oct 155 min read
bottom of page
